Skip to main content
OpenTrials

Clinical trial condition

Thrombocytopenia, Neonatal Alloimmune

Explore clinical trials studying Thrombocytopenia, Neonatal Alloimmune. Study availability and eligibility vary by location and protocol.

10 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Thrombocytopenia, Neonatal Alloimmune trial results

Recruiting

A Study of Nipocalimab in Reducing the Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)

NCT06449651

Conditions
Blood Platelet Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cytopenia, +5 more
Locations
  • Universitair Ziekenhuis Leuven Leuven, Belgium
  • Instituto de Medicina Integral Professor Fernando Figueira Recife, Brazil
  • Instituto D Or de Pesquisa e Ensino IDOR Rio de Janeiro, Brazil
  • Hospital Das Clinicas Da Faculdade De Medicina Da USP São Paulo, Brazil
View all 21 locations
View Trial Details
Recruiting

A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)

NCT06533098

Conditions
Blood Platelet Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cytopenia, +5 more
Locations
  • The University of Alabama at Birmingham Birmingham, Alabama, United States
  • UC Davis School of Medicine Sacramento, California, United States
  • Childrens Hospital Colorado Aurora, Colorado, United States
  • Advocate Children's Hospital Park Ridge, Illinois, United States
View all 26 locations
View Trial Details
Recruiting

The Neonatal Hemorrhagic Risk Assessment in Thrombocytopenia

NCT04598750

Conditions
Bleeding, Blood Platelet Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations
  • Boston Children's Hospital Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Intermountain Medical Center Murray, Utah, United States
  • Utah Valley Hospital Provo, Utah, United States
View Trial Details
Completed

Study to Assess the Occurrence of HPA-1a Alloimmunization in Women With Higher Risk for Fetal and Neonatal Alloimmune Thrombocytopenia

NCT05345561

Conditions
Blood Platelet Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cytopenia, +6 more
Locations
  • New Horizons Clinical Trials, LLC Chandler, Arizona, United States
  • Zillan Clinical Research - Gardena Gardena, California, United States
  • Yale University School of Medicine New Haven, Connecticut, United States
  • University of Miami Miller School of Medicine Miami, Florida, United States
View all 28 locations
View Trial Details
Completed

PRedicting OutcomeS in Preterm nEonates With thromboCyTopenia

NCT06043050

Conditions
Blood Platelet Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cytopenia, +11 more
Locations
  • Charité - Universitätsmedizin Berlin Berlin, Metropolregion Berlin-Brandenburg, Germany
  • Radboud University Medical Center, Amalia Children's hospital Nijmegen, Gelderland, Netherlands
  • Maastricht University Medical Center, MosaKids Maastricht, Limburg, Netherlands
  • Máxima Medical Center Veldhoven, North Brabant, Netherlands
View Trial Details

Related conditions